Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...
Please subscribe to read the full story.
Japan's leading chemical industry newspaper
Footer
© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.
